LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer
Thoracic Cancer · 2024-07 · 15 (19) · 1477-1489
DOI: 10.1111/1759-7714.15323 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 22.05.2024. Verfasst von Shenhui Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, RNA, Long Noncoding, Lung Neoplasms, Cell Proliferation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Social Development Projects of Key R&D Programs in Xuzhou City.
Abstract (Originalsprache)
Background
Lung cancer is the most common malignant tumor. In the present study, we identified a long non‐coding RNA (lncRNA) AC100826.1 (simplify to Lnc1), which was highly expressed in non‐small cell lung cancer (NSCLC) tissues compared with the paracancerous tissues. We also observed the critical role of Lnc1 in regulating the metastasis ability of NSCLC cells.
Methods
RNA sequencing was performed to detect differential expression levels of lncRNAs in NSCLC tissues and its paracancerous tissues. Effects of Lnc1 on cell proliferation, invasion, and migration were determined by CCK‐8, transwell and scratch assays. The xenograft experiment confirmed the effect of Lnc1 on NSCLC cells proliferation and migration abilities in vivo. RT‐qPCR and western blots were performed to determine the expression levels of mRNAs and proteins.
Results
The expression level of Lnc1 was related to multiple pathological results, knockdown of Lnc1 can inhibit the proliferation and metastasis abilities of NSCLC cells. silencing phospholipase C, β1(PLCB1) can reverse the promoting effects of overexpression Lnc1 on NSCLC cells proliferation and migration abilities. In addition, the Rap1 signaling pathway was implicated in the regulation of Lnc1 in NSCLC metastasis.
Conclusion
Our results suggest that Lnc1 regulated the metastatic ability of NSCLC cells through targeting the PLCB1/Rap1 signal pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Thoracic Surgery Laboratory, Xuzhou Medical University, Xuzhou, China.
- Department of Thoracic Surgery, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
ORCID-Profile: Hao Zhang
Förderung
- Social Development Projects of Key R&D Programs in Xuzhou City
Zitieren
APA
Dai, S., Wang, Q., Lyu, Y., Chen, Z., Liu, X., Zhao, G., & Zhang, H. (2024). LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer. Thoracic Cancer, 15(19), 1477-1489. https://doi.org/10.1111/1759-7714.15323
Vancouver
Dai S, Wang Q, Lyu Y, Chen Z, Liu X, Zhao G, et al. LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer. Thoracic Cancer. 2024;15(19):1477-1489. doi:10.1111/1759-7714.15323
BibTeX
@article{Dai2024,
author = {Dai, Shenhui and Wang, Qiao and Lyu, Yin and Chen, Zhipeng and Liu, Xiucheng and Zhao, Guoqing and Zhang, Hao},
title = {LncRNA AC100826.1 regulated PLCB1 to promote progression in non‐small cell lung cancer},
journal = {Thoracic Cancer},
year = {2024},
volume = {15},
number = {19},
pages = {1477--1489},
doi = {10.1111/1759-7714.15323}
}
EUVIMED